270 related articles for article (PubMed ID: 26867833)
1. Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score.
Hostler DC; Marx ES; Moores LK; Petteys SK; Hostler JM; Mitchell JD; Holley PR; Collen JF; Foster BE; Holley AB
Chest; 2016 Feb; 149(2):372-9. PubMed ID: 26867833
[TBL] [Abstract][Full Text] [Related]
2. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.
Decousus H; Tapson VF; Bergmann JF; Chong BH; Froehlich JB; Kakkar AK; Merli GJ; Monreal M; Nakamura M; Pavanello R; Pini M; Piovella F; Spencer FA; Spyropoulos AC; Turpie AG; Zotz RB; Fitzgerald G; Anderson FA;
Chest; 2011 Jan; 139(1):69-79. PubMed ID: 20453069
[TBL] [Abstract][Full Text] [Related]
3. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
[TBL] [Abstract][Full Text] [Related]
4. Assessment of bleeding in chronic liver disease and coagulopathy using the IMPROVE bleeding criteria.
Chamoun N; Ramia E; Lteif C; Salameh P; Zantout H; Ghanem G; Chatila R
Curr Med Res Opin; 2019 Mar; 35(3):427-433. PubMed ID: 30221541
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
[TBL] [Abstract][Full Text] [Related]
6. Risk of falls and bleeding in elderly patients with acute venous thromboembolism.
Kämpfen P; Méan M; Limacher A; Righini M; Jaeger K; Beer HJ; Osterwalder J; Frauchiger B; Matter CM; Kucher N; Cornuz J; Banyai M; Egloff M; Aschwanden M; Bounameaux H; Rodondi N; Aujesky D
J Intern Med; 2014 Oct; 276(4):378-86. PubMed ID: 24645727
[TBL] [Abstract][Full Text] [Related]
7. Compliance with current VTE prophylaxis guidelines and risk factors linked to complications of VTE prophylaxis in medical inpatients: a prospective cohort study in a Spanish internal medicine department.
Novo-Veleiro I; Alvela-Suárez L; Costa-Grille A; Suárez-Dono J; Ferrón-Vidan F; Pose-Reino A
BMJ Open; 2018 May; 8(5):e021288. PubMed ID: 29764885
[TBL] [Abstract][Full Text] [Related]
8. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
9. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry.
Ruíz-Giménez N; Suárez C; González R; Nieto JA; Todolí JA; Samperiz AL; Monreal M;
Thromb Haemost; 2008 Jul; 100(1):26-31. PubMed ID: 18612534
[TBL] [Abstract][Full Text] [Related]
10. Safety of fondaparinux in the prevention of venous thromboembolism in elderly medical patients: results of a single-center, retrospective study.
Silvestri F; Pasca S; Labombarda A; Barbi A; Desideri M; Guidi P; Rogato A; Zaramella M; Bergamo M; Ageno W; Barillari G
Minerva Med; 2014 Jun; 105(3):221-8. PubMed ID: 24988087
[TBL] [Abstract][Full Text] [Related]
11. Association of pharmacologic thromboprophylaxis with clinically relevant bleeding and hospital-acquired anemia in medical inpatients: the risk stratification for hospital-acquired venous thromboembolism in medical patients study.
Choffat D; Rossel JB; Aujesky D; Vollenweider P; Baumgartner C; Méan M
J Thromb Haemost; 2024 Mar; 22(3):765-774. PubMed ID: 38072378
[TBL] [Abstract][Full Text] [Related]
12. Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE risk assessment model.
Maynard GA; Morris TA; Jenkins IH; Stone S; Lee J; Renvall M; Fink E; Schoenhaus R
J Hosp Med; 2010 Jan; 5(1):10-8. PubMed ID: 19753640
[TBL] [Abstract][Full Text] [Related]
13. Routine pharmacological venous thromboembolism prophylaxis in frail older hospitalised patients: where is the evidence?
Greig MF; Rochow SB; Crilly MA; Mangoni AA
Age Ageing; 2013 Jul; 42(4):428-34. PubMed ID: 23557678
[TBL] [Abstract][Full Text] [Related]
14. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
15. External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system.
Rosenberg D; Eichorn A; Alarcon M; McCullagh L; McGinn T; Spyropoulos AC
J Am Heart Assoc; 2014 Nov; 3(6):e001152. PubMed ID: 25404191
[TBL] [Abstract][Full Text] [Related]
16. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism prophylaxis with anticoagulation in septic patients: a prospective cohort study.
Zusman O; Paul M; Farbman L; Daitch V; Akayzen Y; Witberg G; Avni T; Gafter-Gvili A; Leibovici L
QJM; 2015 Mar; 108(3):197-204. PubMed ID: 25190265
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
Bergmann JF; Cohen AT; Tapson VF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Anderson FA;
Thromb Haemost; 2010 Apr; 103(4):736-48. PubMed ID: 20135072
[TBL] [Abstract][Full Text] [Related]
19. Chemoprophylaxis for venous thromboembolism in otolaryngology.
Bahl V; Shuman AG; Hu HM; Jackson CR; Pannucci CJ; Alaniz C; Chepeha DB; Bradford CR
JAMA Otolaryngol Head Neck Surg; 2014 Nov; 140(11):999-1005. PubMed ID: 25275427
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
